A California man tragically succumbed to lung cancer transmitted from a deceased organ donor in a rare medical case. This ...
BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first patient has been ...
The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, ...
Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...
The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...
BNT-321 is under clinical development by BioNTech and currently in Phase I for Pancreatic Ductal Adenocarcinoma.
Mark A. Lewis, MD, discussed the promise of the ESOPEC and TRANSMET trials and the need for their further investigation.
Celebrated volleyball star Janet Wanja died months after being diagnosed with a rare form of cancer. Doctors say gallbladder ...
Zimberelimab is under clinical development by Arcus Biosciences and currently in Phase II for Pancreatic Ductal Adenocarcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback